<DOC>
	<DOCNO>NCT00259311</DOCNO>
	<brief_summary>The purpose study determine whether compound know LY2422347 effective treat people diagnose primary insomnia ( difficulty sleep significant contributing factor , depression ) .</brief_summary>
	<brief_title>Efficacy Study LY2422347 Treat Insomnia</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<criteria>must diagnose primary insomnia must significantly overweight must able visit study doctor 's office every 2 week 8 week willing use handheld electronic device sleep diary every day must able read speak English able see well enough use handheld electronic device patient 's answer question `` During past month , would rate sleep quality overall ? '' must either `` Very Bad '' `` Fairly Bad '' clinically significant and/or uncontrolled condition significant ailment include restless leg syndrome ( RLS ) periodic limb movement disorder ( PLMD ) obstructive sleep apnea ( OSA ) , consider study doctor probable OSA base upon patient history physical examination currently use antidepressant , antipsychotic , stimulant , antihistaminics , medication know effect sleep current previous major psychiatric disorder ( insomnia ) depression , schizophrenia , bipolar disorder , social anxiety , another psychotic disorder .</criteria>
	<gender>All</gender>
	<minimum_age>24 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2007</verification_date>
</DOC>